High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

被引:539
作者
Assmann, G [1 ]
Schulte, H [1 ]
vonEckardstein, A [1 ]
Huang, YD [1 ]
机构
[1] INST KLIN CHEM & LAB MED, ZENT LAB, D-48129 MUNSTER, GERMANY
关键词
high-density lipoprotein (HDL) cholesterol; coronary heart disease (CHD) risk; PROCAM; reverse cholesterol transport;
D O I
10.1016/0021-9150(96)05852-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of coronary heart disease (CHD) was assessed via the Prospective Cardiovascular Munster (PROCAM) study in 19 698 volunteer subjects aged between 16 and 65 years. An adequate incidence of atherosclerotic CHD was only found in male subjects greater than 40 years of age. The analysis and subsequent 6 year follow-up period was, therefore, confined to 4559 male participants aged 40-64 years. In the follow-up period, 186 study participants developed atherosclerotic CHD (134 definite non-fatal myocardial infarctions (MIs) and 52 definite atherosclerotic CHD deaths including 21 sudden cardiac deaths and 31 fatal MIs). Univariate analysis revealed a significant association between the incidence of atherosclerotic CHD and high-density lipoprotein cholesterol (P < 0.001), which remained after adjustment for other risk factors.
引用
收藏
页码:S11 / S20
页数:10
相关论文
共 35 条
  • [11] ENGER SC, 1979, ARTERY, V5, P170
  • [12] FRANCONE OL, 1989, J BIOL CHEM, V264, P7066
  • [13] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
    FRICK, MH
    ELO, O
    HAAPA, K
    HEINONEN, OP
    HEINSALMI, P
    HELO, P
    HUTTUNEN, JK
    KAITANIEMI, P
    KOSKINEN, P
    MANNINEN, V
    MAENPAA, H
    MALKONEN, M
    MANTTARI, M
    NOROLA, S
    PASTERNACK, A
    PIKKARAINEN, J
    ROMO, M
    SJOBLOM, T
    NIKKILA, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
  • [14] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [15] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND INCIDENCE OF CORONARY HEART-DISEASE - ISRAELI ISCHEMIC HEART-DISEASE STUDY
    GOLDBOURT, U
    MEDALIE, JH
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 109 (03) : 296 - 308
  • [16] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY
    GORDON, T
    CASTELLI, WP
    HJORTLAND, MC
    KANNEL, WB
    DAWBER, TR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714
  • [17] HALL WH, 1993, JAMA-J AM MED ASSOC, V269, P505
  • [18] CELL-DERIVED UNESTERIFIED CHOLESTEROL CYCLES BETWEEN DIFFERENT HDLS AND LDL FOR ITS EFFECTIVE ESTERIFICATION IN PLASMA
    HUANG, YD
    VONECKARDSTEIN, A
    ASSMANN, G
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (03): : 445 - 458
  • [19] A PLASMA-LIPOPROTEIN CONTAINING ONLY APOLIPOPROTEIN-E AND WITH GAMMA-MOBILITY ON ELECTROPHORESIS RELEASES CHOLESTEROL FROM CELLS
    HUANG, YD
    VONECKARDSTEIN, A
    WU, SL
    MAEDA, N
    ASSMANN, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) : 1834 - 1838
  • [20] THE HELSINKI HEART-STUDY - CENTRAL FINDINGS AND CLINICAL IMPLICATIONS
    HUTTUNEN, JK
    MANNINEN, V
    MANTTARI, M
    KOSKINEN, P
    ROMO, M
    TENKANEN, L
    HEINONEN, OP
    FRICK, MH
    [J]. ANNALS OF MEDICINE, 1991, 23 (02) : 155 - 159